Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
2025 · 4th Quarter (Oct 1 - Dec 31)
ZAI LAB (US) LLC
Filed by CAPITOL COUNSEL LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 19, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CAPITOL COUNSEL LLC
- Client
- ZAI LAB (US) LLC
- Filing UUID
- a69bd712-a21c-4240-8ed9-df3fa94a2835
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.